🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a Phase III, randomized, double-blind, placebo-controlled, multice...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00282347
Platform adaptive embedded trial for acute respiratory distress syndrome (P...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2022-10-01
Trial ID
NCT05658692
Treatments Being Tested
Bulging of the intervertebral disc in the lumbar part of the spine is one o...
Status
Completed
Location
Faculty of Dental Medicine and Health Osijek
Start Date
2024-09-02
Trial ID
NCT06545812
Treatments Being Tested
This phase IV trial compares the effect of premedication regimens with meth...
Status
Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2025-09-24
Trial ID
NCT07101445
The primary objective is to determine the efficacy of docetaxel plus carbop...
Status
Completed
Location
National University Hospital
Start Date
2007-05
Trial ID
NCT00675545
Treatments Being Tested
A multicenter randomised double-arm clinical trial, to compare safety and e...
Status
Unknown
Location
Iran University of Medical Sciences
Start Date
2022-01-01
Trial ID
NCT03958344
Treatments Being Tested
Mepolizumab is a humanized monoclonal antibody (IgG1, kappa) that blocks in...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-29
Trial ID
NCT04276233
Treatments Being Tested
The purpose of this study is to compare expanded disability status scale, a...
Status
Completed
Location
Kashani Hospital
Start Date
2017-12-01
Trial ID
NCT03315923
Treatments Being Tested
Background: \- The effect of repeated GON-injections has never been studie...
Status
Recruiting
Location
Leiden University Medical Center
Start Date
2022-11-07
Trial ID
NCT05324748
Treatments Being Tested
This compares the effects of nivolumab at a fixed dose of 40 mg with chemo-...
Status
Recruiting
Location
National Research Center for Hematology
Start Date
2022-04-01
Trial ID
NCT06188676